Breaking News Instant updates and real-time market news.

VRX

Valeant

$23.55

-0.69 (-2.85%)

, TEVA

Teva

$23.30

-0.44 (-1.85%)

12:08
07/13/18
07/13
12:08
07/13/18
12:08

Evercore says FDA tentatively approves generic of another top 10 Valeant drug

Evercore ISI analyst Umer Raffat notes that the FDA website shows that a generic version of Valeant's (VRX) Apriso, a top 10 product for the company, has been granted a tentative approval. This approval, which was granted to Teva (TEVA), is the second generic approval for one of the company's top 10 products in the last few days, as a generic Uceris approval was also recently granted, added Raffat in his note to investors. He maintains an In Line rating on Valeant shares.

VRX

Valeant

$23.55

-0.69 (-2.85%)

TEVA

Teva

$23.30

-0.44 (-1.85%)

  • 27

    Aug

  • 10

    Sep

  • 16

    Sep

VRX Valeant
$23.55

-0.69 (-2.85%)

06/22/18
06/22/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Nike (NKE) downgraded to Neutral from Buy at Buckingham with analyst Eric Tracy saying risk/reward is more balanced at current levels and remains positive on Nike's long-term fundamental positioning. 2. Cheesecake Factory (CAKE) downgraded to Hold from Buy at Maxim with analyst Stephen Anderson citing valuation. 3. Horizon Global (HZN) downgraded tow notches to Underperform from Buy at BofA/Merrill with analyst Elizabeth Suzuki saying the company recently terminated its previous plans to acquire Bring Group and withdrew 2018 guidance and the interim CEO is fighting through operational challenges, combined with significant exposure to recently announced tariffs on Chinese goods that adds to earnings uncertainty. 4. Booking Holdings (BKNG) downgraded to Hold from Buy at Benchmark with analyst Daniel Kurnos saying the risk/reward is more balanced at current share levels. 5. Valeant (VRX) downgraded to Hold from Buy at TD Securities. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/27/18
RBCM
06/27/18
NO CHANGE
Target $25
RBCM
Sector Perform
Valeant price target raised to $25 from $19 at RBC Capital
RBC Capital analyst Douglas Miehm raised his price target on Valeant to $25, saying the company's FY18 guidance is likely to prove to be "conservative". The analyst notes the management's commentary that Q1 would mark a trough quarter as its fundamentals are improving, adding that Q2 volumes and price trends for Valeant's largest drug - Xifaxan - point to a strong Q2. Miehm keeps his Sector Perform rating however, citing the likelihood of near-term volatility around the potential delays in its Duobrii psoriasis treatment.
06/28/18
DBAB
06/28/18
NO CHANGE
DBAB
Buy
Deutsche reiterates Buy on Valeant after headquarter visit
Deutsche Bank analyst Gregg Gilbert reiterates a Buy rating on Valeant Pharmaceuticals after visiting the company's headquarters. The analyst left feeling that management is doing the right things to strengthen the business, including investing behind core growth franchises, investing in R&D to support future growth, and strengthening the balance sheet. While keeping his estimates unchanged, Gilbert is more confident in potential drivers of upside, including the growth and durability of the Xifaxan franchise and growth for the Consumer and Bausch and Lomb segments. He continues to like the stock's risk/reward.
06/29/18
MZHO
06/29/18
NO CHANGE
Target $31
MZHO
Buy
Valeant price target raised to $31 from $27 at Mizuho
Mizuho analyst Irina Koffler raised her price target for Valeant Pharmaceuticals to $31 to reflect higher Xifaxan estimates. The analyst views the Xifaxan franchise, and not Valeant's dermatology portfolio, as the key growth driver for the company. She reiterates a Buy rating on Valeant shares.
TEVA Teva
$23.30

-0.44 (-1.85%)

06/18/18
06/18/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Francesca's (FRAN) upgraded to Buy from Neutral at B. Riley FBR with analyst Susan Anderson saying she has increased confidence in the company's turnaround following meetings with management. 2. Chevron (CVX) upgraded to Outperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Chevron offers relatively more leverage than most peers to higher oil prices, which should reach cyclical highs over the next 6 to 12 months, while low WTI exposure maximizes earnings and free cash flow generation. 3. Trovagene (TROV) upgraded to Buy from Hold at Maxim with analyst Jason McCarthy citing the positive news from the company's lead drug candidate PCM-075 as well as its completion of a capital raise. 4. RBS (RBS) upgraded to Buy from Hold at Investec. 5. Teva (TEVA) upgraded to Market Perform from Underperform at Wells Fargo with analyst David Maris citing a "positive meeting" with Teva's CEO Kundefinedre Schultz and CFO Mike McClellan in Israel. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/25/18
GSCO
06/25/18
NO CHANGE
Target $28
GSCO
Buy
Teva price target raised to $28 from $25 at Goldman Sachs
Goldman analyst Jami Rubin raised Buy rated Teva's price target to $28 from $25 following meetings with management last week. The analyst said there has been a "stark shift" by interim management from being fairly reactionary and directionless to now being a company led by leaders who are "action-oriented" with a rapid and clear path to recovery. Rubin said the discussions focused on progress on price cuts, deleveraging, stabilization of the US generics business, specialty opportunities, and the next chapter of growth expected in 2020. The analyst believes guidance is likely to be revised higher as Copaxone has show to be more durable despite generic competition and US generics have stabilized and guidance still assumes ProAir competition this year. Further, Rubin sees upside potential from Austedo and Fremanezumab that could drive EBITDA upside and cash flow for faster debt repayment.
06/27/18
SBSH
06/27/18
NO CHANGE
SBSH
Buy
Teva added to CIti's US Focus List with 'favorable' risk-reward profile
Citi analyst Liav Abraham added Teva to his US Focus List, telling investors in a research note that he continues to see a "favorable" risk-reward profile and that the stock benefits from the most clear and material upside to estimates among the stocks in his coverage universe. He views earnings upside as the most material driver of stock price performance for the specialty pharma sector over the near to medium term, "especially against a backdrop of fundamentals that appear to have stabilized." Looking ahead, Abraham sees a guidance raise along with Q2 earnings.
07/12/18
GSCO
07/12/18
DOWNGRADE
Target $74
GSCO
Sell
Perrigo downgraded to Sell from Neutral at Goldman Sachs
Goldman Sachs analyst Jami Rubin downgraded Perrigo (PRGO) to Sell and lowered her price target for the shares to $74 from $78. The analyst sees "no meaningful risk" to estimates but expects the "business to drift" due to a lack of meaningful new launches in the pipeline. The market may also attribute a lower multiple to Perrigo's consumer business as rates rise, which creates downside risk to the equity, Rubin tells investors in a research note. She sees more upside in other stocks, namely Mylan (MYL) and Teva (TEVA).

TODAY'S FREE FLY STORIES

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

13:14
07/21/18
07/21
13:14
07/21/18
13:14
Hot Stocks
Fiat names Jeep head as CEO as Marchionne's health worsens »

In a statement, Fiat…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RACE

Ferrari

$139.98

-2.65 (-1.86%)

, PM

Philip Morris

$84.31

3.41 (4.22%)

13:10
07/21/18
07/21
13:10
07/21/18
13:10
Hot Stocks
Ferrari to name former Philip Morris chairman as CEO »

The Board of Directors of…

RACE

Ferrari

$139.98

-2.65 (-1.86%)

PM

Philip Morris

$84.31

3.41 (4.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, TM

Toyota

$131.87

0.11 (0.08%)

12:51
07/21/18
07/21
12:51
07/21/18
12:51
Periodicals
Amazon, others working to counter Trump's tariff plans, Reuters says »

Big companies in the…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

TM

Toyota

$131.87

0.11 (0.08%)

AA

Alcoa

$40.32

-1.36 (-3.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 16

    Aug

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:47
07/21/18
07/21
12:47
07/21/18
12:47
Periodicals
Fiat Chrysler's Sergio Marchionne to step down, NYTimes reports »

Fiat Chrysler's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

12:43
07/21/18
07/21
12:43
07/21/18
12:43
Periodicals
Fiat Chrysler to name Jeep's Manley as CEO, Reuters reports »

Fiat Chrysler has named…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$187.21

-0.14 (-0.07%)

, TCEHY

Tencent

$0.00

(0.00%)

12:40
07/21/18
07/21
12:40
07/21/18
12:40
Periodicals
Alibaba, Tencent in talks to buy stake in WPP's Chinese unit, Reuters says »

Alibaba (BABA) and…

BABA

Alibaba

$187.21

-0.14 (-0.07%)

TCEHY

Tencent

$0.00

(0.00%)

WPP

WPP

$76.08

1.52 (2.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

, NFLX

Netflix

$361.33

-2.81 (-0.77%)

11:24
07/21/18
07/21
11:24
07/21/18
11:24
Periodicals
Amazon, Netflix to face tighter capital markets, Barron's says »

Since the Great…

AMZN

Amazon.com

$1,813.84

0.99 (0.05%)

NFLX

Netflix

$361.33

-2.81 (-0.77%)

TSLA

Tesla

$313.49

-6.85 (-2.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 01

    Aug

  • 07

    Aug

  • 16

    Aug

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

, BLK

BlackRock

$503.01

-1.42 (-0.28%)

11:17
07/21/18
07/21
11:17
07/21/18
11:17
Periodicals
BlackRock, T. Rowe Price look like bargains, Barron's says »

With shares of many…

AB

AllianceBernstein

$29.90

-0.05 (-0.17%)

BLK

BlackRock

$503.01

-1.42 (-0.28%)

BEN

Franklin Resources

$31.99

-0.28 (-0.87%)

IVZ

Invesco

$25.46

-0.245 (-0.95%)

LM

Legg Mason

$33.37

-0.13 (-0.39%)

TROW

T. Rowe Price

$119.87

-0.85 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

  • 27

    Jul

ALV

Autoliv

$104.08

-0.57 (-0.54%)

, VNE

Veoneer

$50.81

-1.81 (-3.44%)

11:12
07/21/18
07/21
11:12
07/21/18
11:12
Periodicals
Automotive spinoffs offer exposure to autonomous, electric future, Barron's says »

Last month, Autoliv (ALV)…

ALV

Autoliv

$104.08

-0.57 (-0.54%)

VNE

Veoneer

$50.81

-1.81 (-3.44%)

DLPH

Delphi Technologies

$44.78

-0.355 (-0.79%)

APTV

Aptiv

$92.95

-2.02 (-2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 08

    Aug

DDAIF

Daimler AG

$0.00

(0.00%)

, FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

07:58
07/21/18
07/21
07:58
07/21/18
07:58
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

DDAIF

Daimler AG

$0.00

(0.00%)

FCAU

Fiat Chrysler

$19.33

-0.195 (-1.00%)

F

Ford

$10.56

-0.115 (-1.08%)

GM

General Motors

$39.39

0.08 (0.20%)

HMC

Honda

$29.18

-0.19 (-0.65%)

NSANY

Nissan

$0.00

(0.00%)

TM

Toyota

$131.87

0.11 (0.08%)

VLKAY

Volkswagen

$0.00

(0.00%)

GOOG

Alphabet

$1,184.77

-2.37 (-0.20%)

GOOGL

Alphabet Class A

$1,198.05

-1.21 (-0.10%)

PFE

Pfizer

$37.33

-0.03 (-0.08%)

NVS

Novartis

$82.28

1.47 (1.82%)

RHHBY

Roche

$0.00

(0.00%)

SNY

Sanofi

$42.38

0.44 (1.05%)

BA

Boeing

$354.92

-0.57 (-0.16%)

MRK

Merck

$62.51

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 23

    Jul

  • 23

    Jul

  • 25

    Jul

  • 25

    Jul

  • 27

    Jul

  • 08

    Aug

  • 15

    Aug

  • 22

    Aug

  • 10

    Sep

  • 10

    Sep

  • 18

    Sep

  • 20

    Oct

  • 23

    Oct

  • 28

    Oct

  • 28

    Oct

  • 28

    Jan

  • 16

    Feb

  • 22

    Mar

ACN

Accenture

$166.47

-0.47 (-0.28%)

, EADSY

Airbus

$0.00

(0.00%)

04:55
07/21/18
07/21
04:55
07/21/18
04:55
Conference/Events
Farnborough International to hold an airshow »

Farnborough International…

ACN

Accenture

$166.47

-0.47 (-0.28%)

EADSY

Airbus

$0.00

(0.00%)

ATI

Allegheny Technologies

$26.65

0.08 (0.30%)

BAESY

BAE Systems

$0.00

(0.00%)

BDRBF

Bombardier

$0.00

(0.00%)

CAE

CAE

$20.96

0.17 (0.82%)

CW

Curtiss-Wright

$125.79

-0.12 (-0.10%)

DASTY

Dassault Systemes

$0.00

(0.00%)

ESLT

Elbit Systems

$118.98

0.64 (0.54%)

LMT

Lockheed Martin

$322.76

3.09 (0.97%)

BA

Boeing

$354.92

-0.57 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 02

    Aug

  • 06

    Aug

  • 16

    Aug

FNWB

First Northwest Bancorp

$16.11

0.36 (2.29%)

17:48
07/20/18
07/20
17:48
07/20/18
17:48
Hot Stocks
First Northwest Bancorp names Terry Anderson chief credit officer »

First Northwest Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FCX

Freeport McMoRan

$15.75

-0.05 (-0.32%)

17:42
07/20/18
07/20
17:42
07/20/18
17:42
Hot Stocks
Freeport McMoRan CAO Michael Arnold to retire »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$74.87

-0.24 (-0.32%)

, XLU

Utilities SPDR

$52.28

-0.39 (-0.74%)

17:39
07/20/18
07/20
17:39
07/20/18
17:39
General news
Week ending ETF Scorecard: Financials lead, Energy slumps »

S&P500 SECTORS:…

XLE

Energy Select Sector SPDR

$74.87

-0.24 (-0.32%)

XLU

Utilities SPDR

$52.28

-0.39 (-0.74%)

IYR

DJ US Real Estate Index Fund

$80.23

-0.68 (-0.84%)

XLP

Consumer Staples Sector SPDR

$52.84

0.3 (0.57%)

XLY

Consumer Discretionary Sector SPDR

$112.15

-0.47 (-0.42%)

XLB

S&P Select Materials SPDR

$58.31

-0.21 (-0.36%)

XLF

Financial Select Sector

$27.57

0.065 (0.24%)

XLV

Health Care Select Sector SPDR

$86.74

-0.17 (-0.20%)

XLK

Technology Select Sector SPDR

$72.55

0.01 (0.01%)

XLI

Industrial Select Sector SPDR

$74.44

-0.09 (-0.12%)

GLD

SPDR Gold Trust

$116.56

0.74 (0.64%)

SLV

iShares Silver Trust

$14.59

0.18 (1.25%)

USO

United States Oil Fund

$14.15

0.025 (0.18%)

UNG

United States Natural Gas Fund

$22.38

-0.06 (-0.27%)

HYG

iShares iBoxx $ High Yield Corporate Bond

$85.62

0.03 (0.04%)

LQD

iShares iBoxx $ Investment Grade Corporate Bond

$115.27

-0.335 (-0.29%)

TLT

iShares 20+ Year Treasury Bond Fund

$120.78

-1.46 (-1.19%)

IEF

iShares 7-10 Year Treasury Bond ETF

$102.21

-0.35 (-0.34%)

SHY

iShares 1-3 Year Treasury Bond

$83.26

-0.005 (-0.01%)

IWD

iShares Russell 1000 Value

$123.07

-0.2897 (-0.23%)

IWF

iShares Russell 1000 Growth

$149.41

-0.04 (-0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRX

Xerox

$25.10

-0.095 (-0.38%)

, FUJIY

Fujifilm

$0.00

(0.00%)

17:25
07/20/18
07/20
17:25
07/20/18
17:25
Hot Stocks
Xerox, Centerview settle matters related to proposed Fuji tie-up »

On July 20, 2018, Xerox…

XRX

Xerox

$25.10

-0.095 (-0.38%)

FUJIY

Fujifilm

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

STON

StoneMor Partners

$3.61

-0.015 (-0.41%)

17:15
07/20/18
07/20
17:15
07/20/18
17:15
Hot Stocks
Breaking Hot Stocks news story on StoneMor Partners »

Oaktree Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEF

Telefonica

$8.70

0.07 (0.81%)

17:11
07/20/18
07/20
17:11
07/20/18
17:11
Downgrade
Telefonica rating change at Goldman Sachs »

Telefonica downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

, USO

United States Oil Fund

$14.15

0.025 (0.18%)

17:04
07/20/18
07/20
17:04
07/20/18
17:04
General news
Weekly CFTC Commitment of Traders highlights »

S&P500 net long 5.5K…

SPY

SPDR S&P 500 ETF Trust

$279.71

-0.24 (-0.09%)

USO

United States Oil Fund

$14.15

0.025 (0.18%)

GLD

SPDR Gold Trust

$116.56

0.74 (0.64%)

FXE

Euro Currency Trust

$112.46

0.83 (0.74%)

FXC

CurrencyShares Canadian Dollar Trust

$75.17

0.81 (1.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZWI

Citizens Community Bancorp

$14.15

(0.00%)

17:02
07/20/18
07/20
17:02
07/20/18
17:02
Syndicate
Breaking Syndicate news story on Citizens Community Bancorp »

Citizens Community…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKD

Parker Drilling

$0.30

-0.0044 (-1.46%)

17:01
07/20/18
07/20
17:01
07/20/18
17:01
Hot Stocks
Breaking Hot Stocks news story on Parker Drilling »

Whitebox Advisors reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

RSLS

ReShape Lifesciences

$1.47

-0.02 (-1.34%)

17:00
07/20/18
07/20
17:00
07/20/18
17:00
Hot Stocks
Breaking Hot Stocks news story on ReShape Lifesciences  »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOX

Box

$26.13

-0.26 (-0.99%)

16:57
07/20/18
07/20
16:57
07/20/18
16:57
Initiation
Box initiated at First Analysis »

Box initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALDX

Aldeyra

$7.95

-0.15 (-1.85%)

16:53
07/20/18
07/20
16:53
07/20/18
16:53
Syndicate
Breaking Syndicate news story on Aldeyra »

Aldeyra files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLRE

Greenlight Capital Re

$14.00

-0.15 (-1.06%)

16:46
07/20/18
07/20
16:46
07/20/18
16:46
Hot Stocks
Greenlight Capital Re announces departure of COO »

Greenlight Capital Ry…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RVI

Retail Value

$34.56

0.2 (0.58%)

16:38
07/20/18
07/20
16:38
07/20/18
16:38
Hot Stocks
Breaking Hot Stocks news story on Retail Value »

Luxor Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.